Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,329 | 91,346 | 56,356 | 52,069 | 74,403 |
| Marketable Securities | 333,323 | 329,668 | 150,040 | 162,090 | 78,141 |
| Receivables | 3,435 | 3,075 | 2,826 | 3,577 | 3,455 |
| TOTAL | $400,279 | $431,328 | $213,958 | $220,425 | $159,448 |
| Non-Current Assets | |||||
| PPE Net | 13,416 | 7,774 | 6,081 | 6,188 | 6,578 |
| Investments And Advances | 0 | 0 | 29,929 | 54,059 | 0 |
| Other Non-Current Assets | 6,423 | 5,619 | 2,680 | 2,123 | 1,823 |
| TOTAL | $19,839 | $13,393 | $38,690 | $62,370 | $8,401 |
| Total Assets | $420,118 | $444,721 | $252,648 | $282,795 | $167,849 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,818 | 1,979 | 2,140 | 2,551 | 2,792 |
| Accounts payable and accrued liabilities | 2,092 | 2,581 | 2,282 | 2,211 | 1,848 |
| Accrued Expenses | 23,797 | 17,396 | 10,346 | 11,746 | 7,410 |
| TOTAL | $35,490 | $32,992 | $25,759 | $28,512 | $24,380 |
| Non-Current Liabilities | |||||
| Long Term Debt | 277 | 692 | 1,106 | 1,518 | 2,095 |
| Deferred Revenues | 6,069 | 9,322 | 10,413 | 11,426 | 11,752 |
| Other Non-Current Liabilities | 356 | 175 | 165 | 154 | 212 |
| TOTAL | $43,388 | $37,640 | $38,667 | $41,205 | $45,759 |
| Total Liabilities | $78,878 | $70,632 | $64,426 | $69,717 | $70,139 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,203 | 39,122 | 39,018 | 33,204 | 27,327 |
| Common Shares | 39 | 39 | 33 | 33 | 27 |
| Retained earnings | -306,562 | -268,859 | -235,447 | -207,470 | -186,206 |
| Other shareholders' equity | -165 | -314 | -114 | -18 | 27 |
| TOTAL | $341,240 | $374,089 | $188,222 | $213,078 | $97,710 |
| Total Liabilities And Equity | $420,118 | $444,721 | $252,648 | $282,795 | $167,849 |